These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 15274394

  • 1. Single nucleotide polymorphisms in MMP1 and MMP3 gene promoters as risk factor in head and neck squamous cell carcinoma.
    Zinzindohoué F, Blons H, Hans S, Loriot MA, Houllier AM, Brasnu D, Laccourreye O, Tregouet DA, Stucker I, Laurent-Puig P.
    Anticancer Res; 2004; 24(3b):2021-6. PubMed ID: 15274394
    [Abstract] [Full Text] [Related]

  • 2. Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China.
    Fang S, Jin X, Wang R, Li Y, Guo W, Wang N, Wang Y, Wen D, Wei L, Zhang J.
    Carcinogenesis; 2005 Feb; 26(2):481-6. PubMed ID: 15528217
    [Abstract] [Full Text] [Related]

  • 3. The function of the SNP in the MMP1 and MMP3 promoter in susceptibility to endometriosis in China.
    Shan K, Ying W, Jian-Hui Z, Wei G, Na W, Yan L.
    Mol Hum Reprod; 2005 Jun; 11(6):423-7. PubMed ID: 15879464
    [Abstract] [Full Text] [Related]

  • 4. Polymorphisms in the promoter regions of matrix metalloproteinases 1 and 3 and cancer risk: a meta-analysis of 50 case-control studies.
    Peng B, Cao L, Wang W, Xian L, Jiang D, Zhao J, Zhang Z, Wang X, Yu L.
    Mutagenesis; 2010 Jan; 25(1):41-8. PubMed ID: 19843588
    [Abstract] [Full Text] [Related]

  • 5. Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.
    Hirata H, Okayama N, Naito K, Inoue R, Yoshihiro S, Matsuyama H, Suehiro Y, Hamanaka Y, Hinoda Y.
    Carcinogenesis; 2004 Dec; 25(12):2379-84. PubMed ID: 15319295
    [Abstract] [Full Text] [Related]

  • 6. Association of matrix metalloproteinase (MMP)-1 promoter polymorphism with head and neck squamous cell carcinoma.
    Hashimoto T, Uchida K, Okayama N, Imate Y, Suehiro Y, Hamanaka Y, Ueyama Y, Shinozaki F, Yamashita H, Hinoda Y.
    Cancer Lett; 2004 Jul 28; 211(1):19-24. PubMed ID: 15194213
    [Abstract] [Full Text] [Related]

  • 7. [Single nucleotide polymorphism in the matrix metalloproteinases promoter is associated with susceptibility to endometriosis and adenomyosis].
    Kang S, Wang Y, Zhang JH, Jin X, Fang SM, Li Y.
    Zhonghua Fu Chan Ke Za Zhi; 2005 Sep 28; 40(9):601-4. PubMed ID: 16202315
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Functional polymorphism of the MMP-1 promoter (-1607 1G/2G) in potentially malignant and malignant head and neck lesions in an Indian population.
    Chaudhary AK, Pandya S, Mehrotra R, Bharti AC, Jain S, Singh M.
    Biomarkers; 2010 Dec 28; 15(8):684-92. PubMed ID: 20860530
    [Abstract] [Full Text] [Related]

  • 10. The functional SNP in the matrix metalloproteinase-3 promoter modifies susceptibility and lymphatic metastasis in esophageal squamous cell carcinoma but not in gastric cardiac adenocarcinoma.
    Zhang J, Jin X, Fang S, Li Y, Wang R, Guo W, Wang N, Wang Y, Wen D, Wei L, Kuang G, Dong Z.
    Carcinogenesis; 2004 Dec 28; 25(12):2519-24. PubMed ID: 15319302
    [Abstract] [Full Text] [Related]

  • 11. Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with mortality in haemodialysis patients.
    Cozzolino M, Biondi ML, Galassi A, Turri O, Brancaccio D, Gallieni M.
    Nephrol Dial Transplant; 2009 Jul 28; 24(7):2207-12. PubMed ID: 19221176
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Association of MMP1, MMP3, MMP9, and MMP12 polymorphisms with risk and clinical course of multiple sclerosis in a Polish population.
    Mirowska-Guzel D, Gromadzka G, Czlonkowski A, Czlonkowska A.
    J Neuroimmunol; 2009 Sep 29; 214(1-2):113-7. PubMed ID: 19628284
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Polymorphism of matrix metalloproteinase genes (MMP1 and MMP3) in patients with varicose veins.
    Kurzawski M, Modrzejewski A, Pawlik A, Droździk M.
    Clin Exp Dermatol; 2009 Jul 29; 34(5):613-7. PubMed ID: 19508478
    [Abstract] [Full Text] [Related]

  • 16. MMP gene polymorphisms as contributors for cleft lip/palate: association with MMP3 but not MMP1.
    Letra A, Silva RA, Menezes R, Astolfi CM, Shinohara A, de Souza AP, Granjeiro JM.
    Arch Oral Biol; 2007 Oct 29; 52(10):954-60. PubMed ID: 17537400
    [Abstract] [Full Text] [Related]

  • 17. Head and neck squamous cell carcinoma is not associated with interleukin-18 promoter gene polymorphisms: a case-control study.
    Asefi V, Mojtahedi Z, Khademi B, Naeimi S, Ghaderi A.
    J Laryngol Otol; 2009 Apr 29; 123(4):444-8. PubMed ID: 18940019
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility.
    Zhu Y, Spitz MR, Lei L, Mills GB, Wu X.
    Cancer Res; 2001 Nov 01; 61(21):7825-9. PubMed ID: 11691799
    [Abstract] [Full Text] [Related]

  • 20. Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer.
    Yu C, Zhou Y, Miao X, Xiong P, Tan W, Lin D.
    Cancer Res; 2004 Oct 15; 64(20):7622-8. PubMed ID: 15492291
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.